E-19
(S)-2,2,4-trimethylpyrrolidinehydrochloride
(S)-2,2,4-三甲基吡咯烷盐酸盐
Application
Elexacaftor (VX-445)
CAS No. 1897428-40-8
C₇H₁₆ClN
All Therapeutic Areas Request a Quote →
Therapeutic Area
Respiratory & Rare Disease
6 intermediates
Area Overview
Respiratory & Rare Disease Portfolio
The portfolio connects respiratory programs represented by cystic-fibrosis and leukotriene-pathway therapies with selected rare-disease programs present in the product catalog.
Classification is based on terminal APIs in the product catalog; product counts update with the catalog.
Representative Terminal APIs
Elexacaftor (VX-445) Montelukast Sapropterin
6 catalog intermediates
Intermediates for this Area
E-20
1,3-Dimethyl-1H-pyrazole-4-sulfonamide
1,3-二甲基-1H-吡唑-4-磺胺
Application
Elexacaftor (VX-445)
CAS No. 88398-53-2
C₅H₉N₃O₂S
E-21
3-(3,3,3-Trifluoro-2,2-dimethylpropoxy)-1H-pyrazole
3-(3,3,3-三氟-2,2-二甲基丙氧基)-1H吡唑
Application
Elexacaftor (VX-445)
CAS No. 2229861-15-6
C₈H₁₁F₃N₂O
E-43
5-Deoxy-L-arabinose phenylhydrazone
5-脱氧-L-阿拉伯糖苯基腙
Application
Sapropterin
CAS No. 59245-36-2
C₁₁H₁₆N₂O₃
H-07
2-(2-(3-(2-(7-Chloro-2-quinolinyl)-ethenylphenyl)-3-hydroxypropyl)phenyl)-2-propanol
2-(2-(3-(2-(7-氯-2-喹啉基)乙烯基)苯基)-3-羟基丙基)苯基-2-丙醇
Application
Montelukast
CAS No. 142569-70-8
C₂₉H₂₈ClNO₂
H-08
2-[1-(Mercaptomethyl)cyclopropyl]acetic acid
2-[1-(巯基甲基)环丙基]乙酸
Application
Montelukast
CAS No. 162515-68-6
C₆H₁₀O₂S
Need intermediates for this therapeutic area?
Ready to source? Our team responds to every inquiry within 24 hours.